Delayed Primary Excision with Subsequent Modification of Radiotherapy Dose for Intermediate Risk Rhabdomyosarcoma (RMS): A Report from the Children's Oncology Group (COG) Soft Tissue Sarcoma Committee

The majority of intermediate risk Rhabdomyosarcoma (RMS) patients have gross residual disease (Group III) after their first operative procedure. It is currently not known if local control rates can be maintained when, following induction chemotherapy, the radiation therapy (RT) dose is decreased aft...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Rodeberg, David A., Wharam, Moody D., Lyden, Elizabeth R., Stoner, Julie A., Brown, Kenneth, Wolden, Suzanne L., Paidas, Charles N., Donaldson, Sarah S., Hawkins, Douglas S., Spunt, Sheri L., Arndt, Carola A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474372/
https://ncbi.nlm.nih.gov/pubmed/25418440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados